AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. The company's product pipeline includes two cell-based and two iTR-based product candidates in development. Its lead cell-based therapeutic candidates in development are AGEX-BAT1 and AGEX-VASC1. Its lead small molecule drug-based therapeutic candidate for iTRTM in discovery is AGEX-iTR1547.
No Data